Patents by Inventor Angela Potts

Angela Potts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060121109
    Abstract: The present invention provides solid dosage formulations of benzoxazole-containing ER?-selective ligands, and processes for their manufacture, more particularly to novel formulations, and processes for their manufacture, that contain the ER?-selective ligand, ERB-041.
    Type: Application
    Filed: November 30, 2005
    Publication date: June 8, 2006
    Applicant: Wyeth
    Inventors: Michael Rowley, Angela Potts, Christopher Wilson, Marc Tesconi, Mannching Ku
  • Publication number: 20050136109
    Abstract: This invention relates to an extended release tableted dosage formulation of the antidepressant venlafaxine hydrochloride or an optical form thereof having improved bioavailability.
    Type: Application
    Filed: October 13, 2004
    Publication date: June 23, 2005
    Applicant: Wyeth
    Inventors: Michael Rowley, Angela Potts, Edward Sims
  • Publication number: 20050129762
    Abstract: This invention relates to novel extended release pharmaceutical dosage forms for orally delivering drugs to mammals, e.g., humans. More particularly, this invention concerns novel dosage forms of water soluble drugs such as venlafaxine, enantiomeric (R or S) forms of venlafaxine, metabolites of venlafaxine such as O-desmethyl venlafaxine (ODV) or enantiomeric (R or S) forms of said metabolites which dosage forms have an extended release profile when taken orally. This invention also provides processes for preparing such dosage forms and methods of using them.
    Type: Application
    Filed: October 13, 2004
    Publication date: June 16, 2005
    Applicant: Wyeth
    Inventors: Nicholas Heaton, Angela Potts, Ian Armstrong, James Provost